A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Clinical trial NCT03024996 · TERMINATED
Trial details
- NCT number
- NCT03024996
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2022-05-03
- Enrollment
- 778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.